
Pioneer the future
with
Genome editing and Bio-DX
_edited.jpg)






02
BioDX
We decode genome sequences using bioinformatics and search for target genes for genome editing. In addition, the Genome Editing Cloud, a cloud-based genome analysis platform, streamlines genome editing research.
OUR WORKS
We create high value-added products that can solve social issues, working with partners in various industries.
OUR PLATFORM
We create high value-added products that can solve social issues, working with partners in various industries.
ABOUT
Company:PtBio Inc.
Headquarter:3-10-23, Kagamiyama, Higashi-hiroshima City, Hiroshima, 739-0046, Japan
Founded:August 30th, 2019
Capital:203.60 million yen
Board Member:
Representative Director :Keisuke OKUHARA
Director :Takashi YAMAMOTO
Outside Director :Yumiko KUSAKABE
Outside Director :Koji TANIGUCHI
Auditor :Hiroki UMENAKA
Number of Employees:24
Full-time Employees 18

OUR TEAM
CEO
CEO
奥原 啓輔
OKUHARA,Keisuke
Keisuke Okuhara is the co-founder and CEO of PtBio inc. He also leads a co-creation consortium between industry and academia (COI-NEXT) to promote “Bio-Digital Transformation” with CTO, Takashi Yamamoto.
He served as a member of Japan Science and Technology Agency (JST), the Cabinet Secretariat, Higashi-Hiroshima City, and then to Hiroshima University. He experienced Entrepreneurship programs such as EDGE sponsored by the Ministry of Education, Culture, Sports, Science, Technology, Program of Start-up incubation from COre Research (SCORE) sponsored by JST, and Blockbuster TOKYO, and then established PtBIo Inc.
科学技術振興機構(JST)、内閣官房、東広島市を経て、広島大学へ。
山本卓と共に、OPERA「ゲノム編集」産学共創コンソーシアム、COI-NEXT「バイオDX産学共創拠点」を構築・運営。
文部科学省EDGEプログラム、JST社会還元加速プログラム(SCORE)、東京都Blockbuster TOKYOを通じて起業。

CTO
CTO
山本 卓
YAMAMOTO,Takashi
Takashi Yamamoto is the co-founder and CTO of PtBio inc. He is the Professor and Director of Hiroshima University Genome editing Innovation Center. He has been a top runner in genome editing research and president of the Japanese Society for genome editing. He promotes all-Japan industry-academia co-creation as the area manager of the OPERA “Genome editing” industry-academia co-creation consortium and the project leader of COI-NEXT to promote “Bio-Digital Transformation” . He also works on developing advanced human resources for genome editing through WISE Program (Doctoral Program for World-leading Innovative & Smart Education) sponsored by the Ministry of Education, Culture, Sports, Science and Technology.
広島大学ゲノム編集イノベーションセンター センター長・教授。
日本のゲノム編集研究のトップランナー、日本ゲノム編集学会 初代会長。
OPERA「ゲノム編集」産学共創コンソーシアムの領域統括、COI-NEXT「バイオDX産学共創拠点」のプロジェクトリーダーとして、オールジャパンの産学共創を推進。
文部科学省 卓越大学院プログラムにより、ゲノム編集先端人材育成にも取組む。
.png)
COO
COO
石井 敦浩
ISHII,Atsuhiro
Atsuhiro ISHII is the COO of PtBio inc.At Arthur D. Little Japan, he was engaged in consulting services such as new business strategy planning and business due diligence mainly in the healthcare and life science fields.
He joined PtBio inc in April 2022 as COO of PtBio inc, attracted by the social implementation of genome editing technology, which is an industrial base technology.
At PtBio inc, he is involved in a wide range of business strategy formulation and business development, as well as fundraising and internal control operations.
Arthur D. Little Japanにて、主にヘルスケア・ライフサイエンス領域の新規事業戦略の立案やビジネスデューデリジェンス等のコンサルティング業務に従事。
産業基盤技術であるゲノム編集技術の社会実装に魅力を感じてプラチナバイオに参画。2022年4月より同社COOに就任。
プラチナバイオでは、事業戦略策定や事業開発をはじめ、資金調達や内部統制の業務に幅広く従事。

社外取締役
Outside Director
日下部 裕美子
KUSAKABE,Yumiko
Goldman Sachs IBD.
PJT leader at Inter-American Development Bank.
Engaged in overseas strategy development work while concurrently serving as CxO and outside director for domestic and international startups.
ゴールドマンサックスIBD。
米州開発銀行にてPJTリーダー歴任。
国内外のスタートアップのCxOや社外取締役を兼任して海外戦略策定業務に従事。
.png)
社外取締役
Outside Director
谷口 弘慈
TANIGUCHI,Koji
Engaged in M&A advisory business. After that, he worked at a securities company in corporate planning, IPO advisory and other venture support services, and then engaged in investment banking. Has been involved in multiple IPO deals mainly in the Kansai region.
メガバンクにてM&Aアドバイザリー業務に従事。その後、証券会社にて経営企画、IPOアドバイザリー業務等ベンチャー支援業務を経て、投資銀行業務に従事。これまで関西を中心に複数のIPO案件に関与。

監査役
Audit & Supervisory Board Member
梅中 宏樹
UMENAKA,Hiroki
Engaged in venture investment business for 13 years, 15 companies went IPO, then engaged in IPO/venture support at Banking Division and PRONEXUS.
Active in the IPO/venture industry for a total of 25 years, mainly in the Kansai area.
13年間ベンチャー投資業務に従事し、投資先15社がIPO。その後、銀行本部、プロネクサスにてIPO・ベンチャー支援に従事。
関西地区を中心に現在までIPO・ベンチャー業界にて通算25年に亘り活動中。






